VeriMomsodium dilauramidoglutamide lysine hamilelikte güvenli mi?
No harmonised CLP classification or SCCS/CIR reproductive safety assessment located in authoritative databases; no peer‑reviewed reproductive or developmental toxicity data identified during review. The substance is a high‑molecular‑weight, zwitterionic/peptidic surfactant‑type material and is expected to have negligible systemic absorption from typical topical cosmetic use, so reproductive hazard and mechanism are not indicated (sources checked: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG).
Pregnancy-safe products containing sodium dilauramidoglutamide lysine
Related ingredients
Frequently asked questions
- sodium dilauramidoglutamide lysine hamilelikte güvenli mi?
- No harmonised CLP classification or SCCS/CIR reproductive safety assessment located in authoritative databases; no peer‑reviewed reproductive or developmental toxicity data identified during review. The substance is a high‑molecular‑weight, zwitterionic/peptidic surfactant‑type material and is expected to have negligible systemic absorption from typical topical cosmetic use, so reproductive hazard and mechanism are not indicated (sources checked: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG).
- sodium dilauramidoglutamide lysine emzirirken güvenli mi?
- No evidence of reproductive/breastfeeding risk or milk transfer data in regulatory assessments or peer‑reviewed literature. Given expected negligible dermal absorption and lack of systemic toxicity data, risk to lactation/breastfed infants is considered negligible (sources checked: CIR, SCCS, PubMed, ECHA, PubChem, CosIng, EWG).
- sodium dilauramidoglutamide lysine bebek cildi için güvenli mi?
- No infant‑specific toxicology data found. Because the ingredient is a large, charged surfactant‑like molecule with likely low adult dermal absorption, hazard and mechanism remain unremarkable. Exposure score increased by +1 for babies (per instructions) to reflect higher exposure/absorption from immature infant skin; no data indicate developmental or reproductive toxicity in infants (sources: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG).
- VeriMom sodium dilauramidoglutamide lysine nasıl puanlıyor?
- VeriMom sodium dilauramidoglutamide lysine'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte sodium dilauramidoglutamide lysine yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.